Literature DB >> 20721759

Dangerous noncompliance: a narrative analysis of a CNN special investigation of mental illness.

Douglas Glick1, Kalman Applbaum.   

Abstract

Prevention of illness has become a central theme in debates over strategies to reduce healthcare costs. Severe mental illness poses a special challenge to the paradigm of rational prevention, the principal strategy of which is adherence to pharmacological therapies. With the contraction in the US of in-patient psychiatric care from the 1960s onwards, the mentally ill have become more visible among the homeless and among those caught up in the penal system. Their characteristic visibility contributes to their image as threatening. The perceived dangerousness and the combined societal and economic costs associated with the illness have generated a heightened, and in some venues even a sensationalized rhetoric surrounding the questions of responsibility and control, which we consider in terms of compliance. Using the linguistic method of discourse analysis, we analyze one high profile instance - an episode of CNN's 'Special Investigations Unit', which aired several times in the summer of 2007 - to demonstrate a narrative linking of the high social costs and failures associated with noncompliance and, therefore, the imperative of enforcing it for the safety of society. Through the semiotic reduction of a 'poetic parallelism', the episode reflects and reinforces existing cultural models for mental illness, including its status as straightforward biological disease amenable to pharmacological therapy but which remains uncontrolled due to widespread noncompliance.

Entities:  

Mesh:

Year:  2010        PMID: 20721759     DOI: 10.1080/13648470.2010.493605

Source DB:  PubMed          Journal:  Anthropol Med        ISSN: 1364-8470


  1 in total

1.  Conversational pursuit of medication compliance in a Therapeutic Community for persons diagnosed with mental disorders.

Authors:  Luigina Mortari; Marco Pino
Journal:  Disabil Rehabil       Date:  2013-09-20       Impact factor: 3.033

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.